For Immediate Release

Contact:  Jay Zager

(860) 644-1551

GERBER SCIENTIFIC ANNOUNCES FISCAL 2006 THIRD QUARTER RESULTS
AND RESTATEMENT OF ITS FISCAL 2006 SECOND QUARTER REPORTED RESULTS

SOUTH WINDSOR, CT - Gerber Scientific, Inc. (NYSE: GRB) today reported a net loss of $0.1 million, or essentially break-even performance on a per share basis, on revenue of $124.6 million for the quarter ended January 31, 2006, compared with a net loss of $0.4 million, or $0.02 per diluted share, on revenue of $124.8 million for the quarter ended January 31, 2005. Foreign currency translation had the effect of decreasing revenue by $5.0 million in the third quarter of fiscal 2006, compared with the third quarter of fiscal 2005.

The net loss for the third quarter of fiscal 2006 was due to higher than anticipated tax expenses, resulting from the Company's inability to record tax benefits on losses in certain tax jurisdictions and a reduction in its estimate of tax benefits associated with export sales. The impact of these factors was approximately $0.8 million.

For the nine months ended January 31, 2006, the Company reported a net loss of $1.3 million, or $0.06 per diluted share, on revenue of $387.3 million, compared with a net loss of $0.8 million, or $0.03 per diluted share, on revenue of $383.9 million for the nine months ended January 31, 2005. The results for the nine months ended January 31, 2006 included a pre-tax debt extinguishment charge recorded in the second quarter of $2.5 million and a $2.3 million tax charge associated with the reversal of a deferred tax asset in the United Kingdom recorded in the first quarter. Excluding the impact of these nonrecurring charges, the Company would have reported net income of $2.6 million, or $0.12 per diluted share for the first nine months of the fiscal year. Foreign currency translation had the effect of decreasing revenue by $2.2 million for the first nine months of the fiscal year, compared with the same period in the prior year.

Commenting on the third quarter results, Marc T. Giles, president and chief executive officer said, "Although our operating performance this quarter was below our desired goals, we were able to demonstrate continued revenue growth, after adjusting for the impact of foreign currency translation, and generate an operating profit of $2.9 million, which was over a 250 percent increase from that reported for the third quarter of the prior year."

Giles added, "We continue to be excited about our new product introductions, with the Sign Making and Specialty Graphic segment's launch of the SOLARA™ UV2 Inkjet Printer and the Ophthalmic Lens Processing segment's launch of the new CMX50 Finer/Polisher toward the end of the quarter. In addition, since the end of the third quarter, we have announced two other product enhancements: the addition of the "Cut-to-Polish" option for the Ophthalmic Lens Processing segment's high-speed Diamond Turning Lathe (DTL) generator series, and the Sign Making and Specialty Graphic segment's launch of the GERBER OMEGA™ 2.5 software for sign making industry applications. We believe that these new product introductions, enhancements to our product offerings and anticipated new product launches during the next several months will continue to drive improved operational performance going forward."

During the third quarter closing process, the Company identified an error in its reported results for the second quarter of fiscal 2006. This error related to an overstatement of foreign exchange transaction losses, which increased the net loss reported in the second quarter of fiscal 2006 by approximately $250 thousand, or $0.01 per diluted share. Accordingly, the Company will restate its financial statements for the second quarter of fiscal 2006 to report a loss of $0.1 million, or $0.01 per diluted share, compared with the loss of $0.4 million, or $0.02 per diluted share previously reported in the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2005. Results for the first six months of fiscal 2006 will be similarly adjusted. This adjustment did not have any impact on the results reported for the third quarter of fiscal 2006 and has been reflected in the first nine months of fiscal 2006 results reported above.

About Gerber Scientific, Inc.
Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four primary businesses: Gerber Scientific Products, Spandex Ltd., Gerber Technology and Gerber Coburn.

Forward-looking Statements:
Statements contained in this news release regarding the Company's expected financial condition, revenue, cash flows, operating results, and product launches are forward-looking statements that involve risks and uncertainties. Actual future results or events may differ materially from these forward-looking statements. Readers are referred to the documents filed by the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2005 and subsequently filed quarterly and current reports, for a discussion of important risks that could cause actual results to differ from those contained or implied in the forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments that could affect the Company's pricing decisions and the timing of product introductions, the potential impact on European revenue from the Waste Electrical and Electronic Equipment Directive or the Restriction of Hazardous Substances Directive, rapid technological advances that could cause the Company's inventory to exceed its needs or become obsolete, the Company's reliance on manufacturers or suppliers to supply inventory to the Company's specifications in a timely and cost effective manner, non-recurring orders from significant customers, delays caused by facility relocations, the elimination of apparel trade quotas, fluctuations in currency exchange rates and international economic conditions that could cause the Company's financial results to be volatile, product liability claims, regulatory changes that could increase costs, the Company's indebtedness, compliance with financial covenants associated with the Company's primary credit agreements, any failure to enhance and diversify the Sign Making and Specialty Graphics segment product lines, a potential loss of market focus as the Company seeks to improve operating efficiencies, and the Company's increased focus on larger wholesale optical laboratories. The Company expressly disclaims any obligation to update any of these forward-looking statements.

    Quarter Ended
    January 31,

 Nine Months Ended
 January 31,

In thousands (except per share amounts)

2006 

2005 

2006 

2005 

Revenue:

     Product sales

$ 109,324 

$ 109,790 

$ 341,117 

$ 339,772 

     Service sales

    15,288 

    14,998 

    46,220 

    44,118 

  124,612 

  124,788 

  387,337 

  383,890 

Costs and Expenses:

     Cost of products sold

78,233 

79,275 

242,303 

241,728 

     Cost of services sold

9,120 

9,289 

28,069 

28,634 

     Selling, general and administrative

28,427 

28,564 

87,310 

86,689 

     Research and development

5,959 

6,509 

18,789 

18,730 

     Restructuring charges

         ---   

         349 

       (231)

      2,594 

   121,739 

  123,986 

  376,240 

  378,375 

Operating income

2,873 

802 

11,097 

5,515 

Other expense, net

(754)

(1,164)

(1,437)

(2,600)

Loss on early extinguishment of debt

 ---  

 ---  

(2,483)

 ---  

Interest expense

       (862)

    (1,576)

    (3,818)

    (5,326)

Earnings (Loss) before income taxes

 1,257 

(1,938)

 3,359 

(2,411)

Provision (Benefit) for income taxes

       1,349 

     (1,557)

      4,658 

     (1,639)

Net loss

$        (92)

$  (381)

$  (1,299)

$     (772)

=======

=======

=======

=======

Loss per share of common stock:

     Basic

$      0.00

$     (0.02)

$      (0.06)

$     (0.03)

     Diluted

$      0.00

$     (0.02)

$      (0.06)

$     (0.03)

Weighted average shares outstanding:

     Basic

22,466 

22,263 

22,371 

22,255 

     Diluted

22,466 

22,263 

22,371 

22,255 

GERBER SCIENTIFIC, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

In thousands

January 31,
     2006     

April 30,       2005    

Assets:

Current Assets:

     Cash and cash equivalents

$    5,055 

$     6,148 

     Accounts receivable, net

81,932 

89,800 

     Inventories

53,683 

52,363 

     Current deferred tax assets

9,424 

7,559 

     Prepaid expenses and other current assets

      6,884 

      5,295 

  156,978 

  161,165 

Property, Plant and Equipment

105,914 

122,444 

     Accumulated depreciation

  (67,710) 

  (82,521) 

    38,204 

    39,923 

Intangible Assets:

     Goodwill

51,246 

52,315 

     Pension intangible asset

1,692 

1,692 

     Patents and other intangible assets, net

      5,069 

      5,392 

    58,007 

    59,399 

Deferred Tax Assets

24,130 

29,788 

Other Assets

      4,069 

      6,014 

$ 281,388 

$ 296,289 

=======

=======

Liabilities and Shareholders' Equity:

Current Liabilities:

     Short-term debt

$      214 

$   29,482 

     Accounts payable

42,381 

47,023 

     Accrued compensation and benefits

19,163 

16,438 

     Other accrued liabilities

17,907 

20,654 

     Deferred revenue

14,030 

15,467 

     Income taxes payable

1,952 

2,822 

     Advances on sales contracts

         717 

         674 

    96,364 

  132,560 

     Accrued pension benefit liability

26,825 

25,264 

     Other liabilities

5,945 

6,399 

     Long-term debt

    40,892 

    16,260 

    73,662 

   47,923 

Commitments and Contingencies

Shareholders' Equity:

     Preferred stock

---  

---  

     Common stock

 232 

 230 

     Additional paid-in capital

 66,995 

 66,045 

     Retained earnings

 66,586 

 67,885 

     Treasury stock, at cost

(13,583)

(13,991)

     Unamortized value of restricted stock grants

(168)

(130)

     Accumulated other comprehensive loss

    (8,700)

     (4,233)

  111,362 

  115,806 

$ 281,388 

$ 296,289 

=======

=======